Prostate Fiducial Marker Placement in Patients on Anticoagulation: Feasibility Prior to Prostate SBRT
Background and Purpose: Fiducial marker placement is required in patients undergoing robotic-based Stereotactic Body Radiotherapy (SBRT) or image-guided radiation therapy (IGRT) for prostate cancer. Many patients take antiplatelet or anticoagulant medication due to other medical comorbidities. They...
Main Authors: | Michelle Iocolano, Seth Blacksburg, Todd Carpenter, Michael Repka, Susan Carbone, Gizem Demircioglu, Maryann Miccio, Aaron Katz, Jonathan Haas |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-02-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.00203/full |
Similar Items
-
Fiducial-free CyberKnife stereotactic body radiation therapy (SBRT) for single vertebral body metastases: acceptable local control and normal tissue tolerance with 5 fraction approach
by: Beant S Gill, et al.
Published: (2012-04-01) -
Translating the Immunobiology of SBRT to Novel Therapeutic Combinations for Advanced Prostate Cancer
by: Victor R. Adorno Febles, et al.
Published: (2020-05-01) -
Estimating intrafraction tumor motion during fiducial-based liver stereotactic radiotherapy via an iterative closest point (ICP) algorithm
by: Wu-zhou Li, et al.
Published: (2019-10-01) -
Quality of Life and Toxicity after SBRT for Organ-Confined Prostate Cancer, a Seven Year Study
by: Alan Jay Katz, et al.
Published: (2014-10-01) -
Extreme Hypofractionation with SBRT in Localized Prostate Cancer
by: Maria Antonia Gómez-Aparicio, et al.
Published: (2021-08-01)